開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
通知顯示,印度自8月3日起將汽油出口的暴利稅從每升2.5盧比提高至每升3.5盧比。
2026-08-03
通知顯示,印度自8月3日起將汽油出口的暴利稅從每升2.5盧比提高至每升3.5盧比。
返回
其他消息
2026-08-03
阿里巴巴(BABA.N)盤前漲超4%,此前發佈千問3.8-MAX人工智能模型。
阿里巴巴(BABA.N)盤前漲超4%,此前發佈千問3.8-MAX人工智能模型。
2026-08-03
Led by the Hubei provincial medical insurance bureau, the fourth national centralised procurement for proprietary Chinese medicines published full results. The tender set 28 procurement groups and covered 89 commonly used proprietary Chinese medicines, including OTC and exclusive varieties, representing a market of more than CNY45 bln; over 40,000 public medical institutions reported purchase volumes. A total of 344 firms submitted 468 products; 243 firms with 310 product specifications won. Ove
Led by the Hubei provincial medical insurance bureau, the fourth national centralised procurement for proprietary Chinese medicines published full results. The tender set 28 procurement groups and covered 89 commonly used proprietary Chinese medicines, including OTC and exclusive varieties, representing a market of more than CNY45 bln; over 40,000 public medical institutions reported purchase volumes. A total of 344 firms submitted 468 products; 243 firms with 310 product specifications won. Overall average price cuts exceeded 50%. The procurement used a composite scoring model (price 60%, technical evaluation 40%) and introduced reinstatement/supplementary lists and A/B grouping competition, moving away from lowest-price-only selection to incorporate drug quality, clinical value and supply stability. Industry analysts said the round accelerates alignment of in-hospital and retail pricing, will concentrate share with firms that have scale, supply-chain and quality-control advantages, and is likely to accelerate exit by smaller players lacking core barriers.
Chat with us
, powered by
LiveChat